The current requirement for biomarkers to detect hepatitis B virus (HBV) infection is polarized. One is a fully-automated and highly sensitive measurement system; the other is a simple system for point-of-care testing (POCT) in resource-limited areas. Hepatitis B core-related antigen (HBcrAg) reflects intrahepatic covalently closed circular DNA and serum HBV DNA. Even in patients with undetectable serum HBV DNA or HBsAg loss, HBcrAg may remain detectable. Decreased HBcrAg levels are associated with reduction of the occurrence of hepatocellular carcinoma (HCC) in chronic hepatitis B. Recently, a fully-automated, novel high-sensitivity HBcrAg assay (iTACT-HBcrAg, cut-off value: 2.1 logIU/mL) has been developed. This attractive assay has been released in Japan very recently. iTACT-HBcrAg can be useful for monitoring HBV reactivation and prediction of HCC occurrence, as an alternative to HBV DNA. Moreover, monitoring HBcrAg may be suitable for determining the therapeutic effectiveness of approved drugs and novel drugs under development. Presently, international guidelines recommend anti-HBV prophylaxis for pregnant women with high viral loads to prevent mother-to-child transmission of HBV. However, >95% of HBV-infected individuals live in countries where HBV DNA quantification is not available. Worldwide elimination of HBV needs the scaling-up of examination and medication services in resource-limited areas. Based on this situation, a rapid and easy HBcrAg assay as a POCT is valuable. This review provides the latest information regarding the clinical use of a new surrogate marker, HBcrAg, in HBV management, based on iTACT-HBcrAg or POCT, and introduces novel agents targeting HBV RNA/protein.
Citations
Citations to this article as recorded by
Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study Byungyoon Yun, Juyeon Oh, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon Annals of Hepatology.2026; 31(1): 102175. CrossRef
Strategic analysis of hepatitis B virus serological profile and the diagnostic utility of HBcrAg across Osun and Plateau State, Nigeria Priscilla Abechi, Uwem E. George, Olamide Y. Aborisade, Arthur O. Oragwa, Oluwatomisin P. Osijonwo, Oluremi I. Ajayi, Olusola A. Ogunsanya, Christian Happi, Onikepe A. Folarin Journal of Immunoassay and Immunochemistry.2026; 47(2): 129. CrossRef
High Intrahepatic cccDNA in Resolved HBV Infection: Insights From Living Donor Liver Transplantation With Anti‐HBc‐Positive Grafts Sung Kwan Bae, Nobuhisa Akamatsu, Akihiko Ichida, Yujiro Nishioka, Yoshinori Inagaki, Nozomi Miyake, Takeshi Takamoto, Yoshikuni Kawaguchi, Sumihito Tamura, Junichi Arita, Junichi Kaneko, Motoyuki Otsuka, Yasuhito Tanaka, Hiroshi Yotsuyanagi, Kyoji Moriya Journal of Gastroenterology and Hepatology.2026; 41(4): 1335. CrossRef
Analysis of HBV Genome Integration in Patients With HBV‐Previously Infected NBNC‐HCC Tomoya Saito, Rigel Suzuki, Akhinur Rahman, Kento Mori, Samiul Alam Rajib, Nobuhiro Kobayashi, Yoichi Yamamoto, Sharmin Nahar Sithi, Takaya Ichikawa, Tatsuya Orimo, Tatsuhiko Kakisaka, Lihan Liang, Naganori Nao, Saori Suzuki, Tomokazu Tamura, Yorifumi Sat Hepatology Research.2026;[Epub] CrossRef
Clinical utility of hepatitis B core-related antigen in chronic hepatitis B infection: diagnostic, prognostic, and therapeutic implications Bukhari Isah Shuaib, Usman Linda Itunu, Aminat Daud Egyptian Liver Journal.2026;[Epub] CrossRef
Host Factors DDB2 and DNA Polymerase Delta Are Linked to cccDNA Persistence in Hepatitis B Virus and Occult Hepatitis B Virus‐Related Hepatocellular Carcinoma Kanyakorn Singsung, Athaya Vorasittha, Pisit Tangkijvanich, Yasuhito Tanaka, Natthaya Chuaypen, Pongserath Sirichindakul Journal of Viral Hepatitis.2026;[Epub] CrossRef
Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study Masanori Fukushima, Satoshi Miuma, Yasuhiko Nakao, Ryu Sasaki, Masafumi Haraguchi, Hisamitsu Miyaaki Journal of Clinical Medicine.2026; 15(11): 4021. CrossRef
Rapid test for hepatitis B core-related antigen to identify people living with hepatitis B having high viral load in Cameroon Richard Njouom, Alassane Ndiaye, Abdou Fatawou Modiyinji, Frederic Lissock, Jeanne Perpétue Vincent, Masaya Baba, Naoki Yamamoto, Atsushi Kaneko, Katsumi Aoyagi, Naofumi Hashimoto, Mari Nagai, Masato Ichikawa, Tetsuo Miura, Wataru Sugiura, Yasuhito Tanaka Virology.2025; 602: 110316. CrossRef
Achieving chronic hepatitis B functional cure: Factors and potential mechanisms Jiarui Zheng, Zilong Wang, Linxiang Huang, Zixuan Qiu, Yandi Xie, Suzhen Jiang, Bo Feng Virus Research.2025; 351: 199507. CrossRef
Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B Takuya Matsubara, Satoru Hagiwara, Naoshi Nishida, Naoya Omaru, Akihiro Yoshida, Tomoki Yamamoto, Yoriaki Komeda, Mamoru Takenaka, Masatoshi Kudo Scientific Reports.2025;[Epub] CrossRef
Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients Qiyao Wei, Jing Zhao BMC Gastroenterology.2025;[Epub] CrossRef
Antiviral Therapy-Induced Changes in Long Non-Coding RNA Expression Profiles in Umbilical Cord Blood and Placental Tissues of Hepatitis B Virus-Infected Pregnant Women Cuimin Wang, Yuting Huang, Lanfeng Li, Xizhen Huang, Yin Huang, Xiang Fang, Yu Long International Journal of Women's Health.2025; Volume 17: 835. CrossRef
Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV‐Related HCC Beom Kyung Kim Alimentary Pharmacology & Therapeutics.2025; 61(10): 1717. CrossRef
Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV‐Related HCC—Authors' Reply Subin Heo, Won‐Mook Choi Alimentary Pharmacology & Therapeutics.2025; 61(10): 1719. CrossRef
HBcrAg Dynamic Change During Treatment Predicts HBsAg Loss in Pediatric Patients With Chronic Hepatitis B Ling Ye, Wenxian Ouyang, Yingping Gu, Zhenzhen Yao, Xin Lai, Sisi Li, Meng Yang, Songxu Peng Journal of Medical Virology.2025;[Epub] CrossRef
Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani Health Science Reports.2025;[Epub] CrossRef
Future Perspectives of Liver Research in the Asia‐Pacific Region: Focus on Hepatitis B and C Beom Kyung Kim Journal of Gastroenterology and Hepatology.2025; 40(8): 1855. CrossRef
Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, Hironori Ochi, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung K Journal of Gastroenterology and Hepatology.2025; 40(6): 1595. CrossRef
Hepatitis B core-related antigen as a predictive biomarker for recurrence in primary hepatocellular carcinoma: A meta-analysis Ling-Bo Liang, Hai-Jun Zhang, Feng Liu, Qiao-Li Su World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef
Construction and validation of a nomogram prediction model for antiviral efficacy based on clinical characteristics and intestinal microflora distribution in patients with chronic hepatitis B Hongjie Wu, Mingqiang Yue, Tianbao Wang, Xiaoxia Wei, Yanping Wang, Changyun Si Frontiers in Medicine.2025;[Epub] CrossRef
Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α: A study with an 11- to 173-month follow-up Wen Deng, Hongxiao Hao, Ziyu Zhang, Xinxin Li, Weihua Cao, Yaqin Zhang, Shiyu Wang, Zixuan Gao, Linmei Yao, Shuojie Wang, Xin Wei, Wei Yi, Linqing Zhao, Yao Xie, Minghui Li Virologica Sinica.2025; 40(4): 579. CrossRef
Discontinuation of nucleos(t)ide analogues after NA-induced HBsAg seroclearance: a single-center 48-week retrospective study Yong-Hong Wang, Ya-Chao Tao, Meng-Lan Wang, Cheng-Run Song, Jiang-Nan Peng, En-Qiang Chen Journal of Virus Eradication.2025; 11(4): 100617. CrossRef
An RNA‐degrading enzyme emerges as a biomarker in a study of human hepatitis virus B Takehisa Watanabe, Katsuya Nagaoka Hepatology Research.2024; 54(3): 220. CrossRef
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy Ritsuzo Kozuka, Masaru Enomoto, Yoshimi Yukawa‐Muto, Naoshi Odagiri, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida‐Kobayashi, Norifumi Kawada Hepatology Research.2024; 54(7): 615. CrossRef
Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B Tomohiro Nishikawa, Masahiro Matsui, Saori Onishi, Kosuke Ushiro, Akira Asai, Soo-Ki Kim, Hiroki Nishikawa International Journal of Molecular Sciences.2024; 25(4): 2245. CrossRef
Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment Lisa Sandmann, Birgit Bremer, Valerie Ohlendorf, Jerzy Jaroszewicz, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy Viruses.2024; 16(2): 255. CrossRef
Identification of dihydroquinolizinone derivatives with nitrogen heterocycle moieties as new anti-HBV agents Huijuan Song, Shangze Yang, Shuo Wu, Xiaoyu Qin, Ya Wang, Xican Ma, Jiaqi Gong, Meng Wei, Apeng Wang, Mengyuan Wang, Kun Lan, Juan Guo, Mingliang Liu, Xingjuan Chen, Yuhuan Li, Kai Lv European Journal of Medicinal Chemistry.2024; 268: 116280. CrossRef
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B Yong-Hong Wang, Hong Tang, En-Qiang Chen Viruses.2024; 16(4): 529. CrossRef
Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu Clinical and Molecular Hepatology.2024; 30(2): 293. CrossRef
Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu Clinical and Molecular Hepatology.2024; 30(2): 276. CrossRef
Current perspectives of viral hepatitis Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef
Two Concepts of Hepatitis B Core-Related Antigen Assay: A Highly Sensitive and Rapid Assay or an Effective Tool for Widespread Screening Takako Inoue, Shintaro Yagi, Yasuhito Tanaka Viruses.2024; 16(6): 848. CrossRef
Novel biomarkers for chronic hepatitis B management Tai-Chung Tseng Clinical Liver Disease.2024;[Epub] CrossRef
Role of circular RNAs in preeclampsia (Review) Hengxue Jiang, Tao Meng, Ziwei Li Experimental and Therapeutic Medicine.2024;[Epub] CrossRef
Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus Philippa C. Matthews, Ponsiano Ocama, Su Wang, Manal El-Sayed, Anna Turkova, Deborah Ford, Judith Torimiro, Ana Cristina Garcia Ferreira, Angélica Espinosa Miranda, Fernando Pio De La Hoz Restrepo, Emmanuel Seremba, Robinson Mbu, Calvin Q. Pan, Homie Raza JHEP Reports.2023; 5(8): 100777. CrossRef
First
Prev
